NAFDAC alerts Nigerians against fake injection in circulation
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, particularly healthcare providers, to one batch of counterfeit Meronem 1g injection being purchased in Nigeria.
The information is contained in a public alert No. 036/2023, signed by the agency’s Director-General, Prof. Mojisola Adeyeye.
Adeyeye said the Marketing Authorization Holder (MAH), Pfizer, reported the incident, as received through a patient notification platform, concerning a suspicious Meronem 1g injection purchase.
She reported Pfizer as saying that the vial content did not dissolve when reconstituted for use and that further visual inspection of the pack was observed.
It was also reported that the crimp code did not match the code reported on the production documentation batch of 2A21F11, the semi-finished batch used for 4A21I17.
The D-G said that the production process did not meet Pfizer’s specifications.
She also implored importers, wholesalers, and retailers to maintain vigilance within the supply chain and desist from the illegal importation, distribution, and sale of counterfeit Meronem 1g injection and other substandard medicinal products.
Adeyeye said that anybody in possession of the counterfeit product should stop using it and submit it to the nearest NAFDAC office.
